Erin K. Crane

828 total citations
38 papers, 535 citations indexed

About

Erin K. Crane is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Erin K. Crane has authored 38 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Reproductive Medicine, 18 papers in Obstetrics and Gynecology and 14 papers in Surgery. Recurrent topics in Erin K. Crane's work include Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (17 papers) and Uterine Myomas and Treatments (9 papers). Erin K. Crane is often cited by papers focused on Endometrial and Cervical Cancer Treatments (17 papers), Ovarian cancer diagnosis and treatment (17 papers) and Uterine Myomas and Treatments (9 papers). Erin K. Crane collaborates with scholars based in United States, Austria and United Kingdom. Erin K. Crane's co-authors include Jubilee Brown, R. Wendel Naumann, David L. Tait, Robert V. Higgins, David M. Gershenson, Alpa M. Nick, Heather J. Dalton, Wei Hu, Anil K. Sood and Anaís Malpica and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Erin K. Crane

36 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin K. Crane United States 13 205 195 161 126 109 38 535
Rosanna Mancari Italy 16 356 1.7× 194 1.0× 234 1.5× 115 0.9× 103 0.9× 33 619
Maria Elena Guerrieri Italy 13 166 0.8× 169 0.9× 188 1.2× 128 1.0× 113 1.0× 27 535
Ramya P. Masand United States 12 267 1.3× 103 0.5× 246 1.5× 192 1.5× 128 1.2× 37 664
Tomoyuki Ichimura Japan 13 216 1.1× 144 0.7× 269 1.7× 59 0.5× 96 0.9× 49 549
Maxine L. Crook Australia 17 199 1.0× 136 0.7× 211 1.3× 82 0.7× 211 1.9× 35 613
Lucía González‐Cortijo Spain 11 179 0.9× 108 0.6× 192 1.2× 94 0.7× 72 0.7× 26 434
Min Sung An South Korea 12 217 1.1× 155 0.8× 151 0.9× 145 1.2× 91 0.8× 42 705
Anne M. van Altena Netherlands 16 390 1.9× 125 0.6× 247 1.5× 127 1.0× 63 0.6× 48 594
Ashanti Zampa Italy 13 158 0.8× 70 0.4× 254 1.6× 157 1.2× 88 0.8× 21 517
Birgit Volgger Austria 11 371 1.8× 257 1.3× 134 0.8× 214 1.7× 82 0.8× 17 644

Countries citing papers authored by Erin K. Crane

Since Specialization
Citations

This map shows the geographic impact of Erin K. Crane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin K. Crane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin K. Crane more than expected).

Fields of papers citing papers by Erin K. Crane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin K. Crane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin K. Crane. The network helps show where Erin K. Crane may publish in the future.

Co-authorship network of co-authors of Erin K. Crane

This figure shows the co-authorship network connecting the top 25 collaborators of Erin K. Crane. A scholar is included among the top collaborators of Erin K. Crane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin K. Crane. Erin K. Crane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duska, Linda, Gina R. Petroni, Premal H. Thaker, et al.. (2025). Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer. Cancer. 131(4). e35757–e35757. 3 indexed citations
2.
Crane, Erin K., Stéphanie Gaillard, & Martee L. Hensley. (2025). Rare Uterine Tumors: What to Do?. American Society of Clinical Oncology Educational Book. 45(3). e473106–e473106.
3.
4.
Duska, Linda, Laura L. Holman, Erin K. Crane, et al.. (2023). A randomized phase II study of chemoradiation and pembrolizumab for locally advanced cervical cancer (005). Gynecologic Oncology. 176. S5–S5. 2 indexed citations
5.
Lees, Brittany, Shelby L. Johnson, Jubilee Brown, et al.. (2022). Improved Rates of Same-day Discharge in Patients Undergoing Surgery for Endometrial Cancer Following the COVID-19 Pandemic. Journal of Minimally Invasive Gynecology. 29(11). 1248–1252. 5 indexed citations
6.
Crane, Erin K.. (2022). Beyond Serous: Treatment Options for Rare Endometrial Cancers. Current Treatment Options in Oncology. 23(11). 1590–1600. 3 indexed citations
7.
Crane, Erin K., Laura Chambers, Robert Debernardo, et al.. (2021). Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: the MIID-SOC trial. Gynecologic Oncology. 162. S19–S20. 2 indexed citations
8.
Crane, Erin K., et al.. (2021). Perioperative Recovery and Narcotic Use in Laparoscopic versus Robotic Surgery for Endometrial Cancer. Journal of Minimally Invasive Gynecology. 28(11). 1898–1902. 1 indexed citations
9.
Brown, Jubilee, et al.. (2020). Pre-emptive Non-narcotic Pain Medication before Minimally Invasive Surgery in Gynecologic Oncology. Journal of Minimally Invasive Gynecology. 28(4). 811–816. 4 indexed citations
10.
Tait, David L., et al.. (2020). Comparison of Perioperative Outcomes between Minimally Invasive Sentinel Node Biopsy and Full Lymphadenectomy for Endometrial Cancer. Journal of Minimally Invasive Gynecology. 28(8). 1514–1518. 1 indexed citations
11.
Duska, Linda, Jennifer Scalici, Sarah M. Temkin, et al.. (2020). Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer. Cancer. 126(22). 4948–4956. 45 indexed citations
12.
Brown, Jubilee, et al.. (2020). Outcomes of Minimally Invasive versus Open Radical Hysterectomy for Early Stage Cervical Cancer Incorporating 2018 FIGO Staging. Journal of Minimally Invasive Gynecology. 28(4). 824–828. 8 indexed citations
13.
Naumann, R. Wendel, David L. Tait, Robert V. Higgins, et al.. (2018). Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer. Gynecologic Oncology. 151(3). 477–480. 21 indexed citations
14.
Brown, Jubilee, Erin K. Crane, William E. Anderson, et al.. (2018). When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer. Journal of Minimally Invasive Gynecology. 26(5). 902–909. 30 indexed citations
15.
16.
Crane, Erin K. & Jubilee Brown. (2018). Early stage mucinous ovarian cancer: A review. Gynecologic Oncology. 149(3). 598–604. 16 indexed citations
17.
Crane, Erin K., Yvonne T.M. Tsang, Lisa K. Mullany, et al.. (2015). Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas. PLoS ONE. 10(8). e0135101–e0135101. 39 indexed citations
18.
Crane, Erin K., et al.. (2015). Levonorgestrel Intrauterine Device Placement in a Premenopausal Breast Cancer Patient with a Bicornuate Uterus. Journal of Minimally Invasive Gynecology. 23(1). 133–135. 4 indexed citations
19.
Bottsford-Miller, Justin, Hyun Jin Choi, Heather J. Dalton, et al.. (2014). Differential Platelet Levels Affect Response to Taxane-Based Therapy in Ovarian Cancer. Clinical Cancer Research. 21(3). 602–610. 73 indexed citations
20.
Tucker, Susan L., Kshipra M. Gharpure, Shelley M. Herbrich, et al.. (2014). Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 20(12). 3280–3288. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosanna Mancari Breakdown of academic impact, for papers by Maria Elena Guerrieri Breakdown of academic impact, for papers by Ramya P. Masand Breakdown of academic impact, for papers by Tomoyuki Ichimura Breakdown of academic impact, for papers by Maxine L. Crook Breakdown of academic impact, for papers by Lucía González‐Cortijo Breakdown of academic impact, for papers by Min Sung An Breakdown of academic impact, for papers by Anne M. van Altena Breakdown of academic impact, for papers by Ashanti Zampa Breakdown of academic impact, for papers by Birgit Volgger
Rankless by CCL
2026